Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the study record history.SummaryDifference0.0%

- Check19 days agoChange DetectedA new version entry dated 2026-03-16 with a Study Status update was added to the record history, and an entry dated 2026-02-13 was removed.SummaryDifference0.2%

- Check26 days agoChange DetectedAdded Revision: v3.4.3 to the history and removed Revision: v3.4.2 from the history.SummaryDifference0.0%

- Check47 days agoChange DetectedVersion 86 (2026-02-13) adds Contacts/Locations and Study Status to the record history, and the 2026-02-02 entry was removed.SummaryDifference0.2%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 to the page history. Removed the funding-lapse notice and the prior Revision: v3.4.1 banner.SummaryDifference0.3%

- Check61 days agoChange DetectedContacts/Locations and Study Status have been added, providing current trial locations and status details. A site-wide government funding notice has also been added, and the previous revision v3.4.0 was deleted.SummaryDifference0.5%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.